Porr, Caroline J.
Rios, Patricia
Bajaj, Harpreet S.
Egan, Aoife M.
Huot, Celine
Batten, Ryan
Bishop, Lisa
Ryan, Devonne
Davis, Erin
Darvesh, Nazia
Rahman, Arifur
Asghari, Shabnam
Acheampong, Lily
Tricco, Andrea C. http://orcid.org/0000-0002-4114-8971
Funding for this research was provided by:
Canada Research Chairs (17-0126-AWA)
Canadian Institutes of Health Research (GSR-154442)
Health Research Board (CBES-2018-001)
Article History
Received: 12 November 2019
Accepted: 17 June 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Andrea Tricco is a member of the editorial board at BMC Systematic Reviews, but was not involved with the peer review process/decision to publish this manuscript. Harpreet Bajaj is involved in honoraria and/or research support, outside the submitted work from Abbott, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi and Valeant. Celine Huot is involved as a local principal investigator in clinical trials for the treatment of diabetes in the pediatric population: Novo Nordisk and Sanofi Aventis. All other authors have no known conflicts of interest to declare.